CollPlant Biotechnologies (CLGN) EPS (Basic) Growth (1y) (2018 - 2026)
CollPlant Biotechnologies (CLGN) EPS (Basic) Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.57 Bn | 130.72 Bn | 2.84 Bn | 7.74% |
| 2 | Regeneron Pharmaceuticals | 85.99 Bn | 77.99 Bn | 3.93 Bn | -4.72% |
| 3 | Argenx Se | 65.00 Bn | 59.82 Bn | 1.37 Bn | 88.81% |
| 4 | Moderna | 56.27 Bn | 51.13 Bn | 52.00 Mn | 7.59% |
| 5 | BeOne Medicines | 42.00 Bn | 36.90 Bn | 1.53 Bn | 143.95% |
| 6 | Alnylam Pharmaceuticals | 31.60 Bn | 28.29 Bn | 992.69 Mn | 322.67% |
| 7 | BioNTech SE | 27.68 Bn | 9.29 Bn | 668.28 Mn | -147.33% |
| 8 | Insmed | 27.43 Bn | 26.27 Bn | 358.27 Mn | 96.41% |
| 9 | Royalty Pharma | 27.34 Bn | 26.51 Bn | - | -16.29% |
| 10 | CollPlant Biotechnologies | 4.26 Mn | 4.26 Mn | -243,000.00 | -57.49% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 30, 2026 | -57.49% |
| Dec 31, 2025 | -536.82% |
| Sep 30, 2025 | 29.77% |
| Jun 30, 2025 | -26.79% |
| Mar 30, 2025 | -445,353,594.31% |
| Dec 31, 2024 | 6.68% |
| Sep 30, 2024 | 4.74% |
| Jun 30, 2024 | -27.99% |
| Mar 31, 2024 | 10.34% |
| Dec 31, 2023 | -1,247,706,470.58% |
| Sep 30, 2023 | -1,142,022,577.69% |
| Jun 30, 2023 | 27.52% |
| Mar 31, 2023 | -12.30% |
| Dec 31, 2022 | 190.35% |
| Sep 30, 2022 | 230.66% |
| Jun 30, 2022 | 19.62% |
| Mar 31, 2022 | -76.59% |
| Dec 31, 2021 | 78.62% |
| Sep 30, 2021 | -292.27% |
| Jun 30, 2021 | -26.92% |